Ixico Says Two Huntington's Disease Programs Discontinued by Sponsors

04:48 AM EDT, 07/13/2026 (MT Newswires) -- Ixico (IXI.L) said Monday that two Huntington's disease programs it was supporting were discontinued by their sponsors. The discontinuation will reduce 1.5 million pounds sterling from the neuroscience imaging and biomarker analytics company's contracted order book within the next two financial years.